A patient who lost weight but developed fatigue, constipation, under-eating, or muscle weakness may need a different strategy than a patient who lost weight steadily, maintained strength, and improved lab markers
Side Effect Tolerance: How sensitive are you to potential GI issues
(6.1) To report SUSPECTED ADVERSE REACTIONS, contact Novo Nordisk Inc., at 1-833-934-6891 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Q4 2024: Novo Nordisk and Flagship Pioneering launch partnership to develop novel GLP-1-based therapeutics Novo Nordisk and Flagship Pioneering announced a multi-year partnership to discover and develop new GLP-1-based therapies for metabolic and chronic diseases, leveraging Flagships bioplatform companies
M., Young, R
It contains L-Carnitine, Apple Cider Vinegar, Cinnamon, and vitamins B6 & B12